[go: up one dir, main page]

NO20031830L - Polysubstituerte imidazopyridiner som gastriske sekresjonshemmere - Google Patents

Polysubstituerte imidazopyridiner som gastriske sekresjonshemmere

Info

Publication number
NO20031830L
NO20031830L NO20031830A NO20031830A NO20031830L NO 20031830 L NO20031830 L NO 20031830L NO 20031830 A NO20031830 A NO 20031830A NO 20031830 A NO20031830 A NO 20031830A NO 20031830 L NO20031830 L NO 20031830L
Authority
NO
Norway
Prior art keywords
gastric secretion
secretion inhibitors
imidazopyridines
polysubstituted
polysubstituted imidazopyridines
Prior art date
Application number
NO20031830A
Other languages
English (en)
Other versions
NO20031830D0 (no
NO325736B1 (no
Inventor
Wolfgang-Alexander Simon
Stefan Postius
Wolfgang Kromer
Wilm Buhr
Bernhard Kohl
Joerg Senn-Bilfinger
Peter Zimmermann
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of NO20031830D0 publication Critical patent/NO20031830D0/no
Publication of NO20031830L publication Critical patent/NO20031830L/no
Publication of NO325736B1 publication Critical patent/NO325736B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20031830A 2000-10-25 2003-04-24 Polysubstituerte imidazopyridiner samt anvendelse derav til fremstillinig av medikamenter som gastriske sekresjonshemmere NO325736B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00123133 2000-10-25
PCT/EP2001/012207 WO2002034749A1 (en) 2000-10-25 2001-10-23 Polysubstituted imidazopyridines as gastric secretion inhibitors

Publications (3)

Publication Number Publication Date
NO20031830D0 NO20031830D0 (no) 2003-04-24
NO20031830L true NO20031830L (no) 2003-04-24
NO325736B1 NO325736B1 (no) 2008-07-14

Family

ID=8170193

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031830A NO325736B1 (no) 2000-10-25 2003-04-24 Polysubstituerte imidazopyridiner samt anvendelse derav til fremstillinig av medikamenter som gastriske sekresjonshemmere

Country Status (19)

Country Link
US (2) US6869949B2 (no)
EP (1) EP1332143A1 (no)
JP (1) JP2004512338A (no)
KR (1) KR20040011423A (no)
CN (1) CN1692113A (no)
AU (2) AU1056302A (no)
BR (1) BR0114873A (no)
CA (1) CA2426616A1 (no)
EA (1) EA008151B1 (no)
HR (1) HRP20030323A2 (no)
HU (1) HUP0302308A2 (no)
IL (1) IL154850A0 (no)
MX (1) MXPA03003706A (no)
NO (1) NO325736B1 (no)
NZ (1) NZ525281A (no)
PL (1) PL360412A1 (no)
SK (1) SK5072003A3 (no)
WO (1) WO2002034749A1 (no)
ZA (1) ZA200302038B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1692113A (zh) * 2000-10-25 2005-11-02 奥坦纳医药公司 作为胃分泌抑制剂的多取代咪唑并吡啶
DE10145457A1 (de) * 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
RS72004A (en) 2002-02-15 2006-10-27 Altana Pharma Ag. Tryciclic n-acyl compounds
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines
EP1585516A2 (en) * 2002-12-20 2005-10-19 ALTANA Pharma AG 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
CN1747731A (zh) * 2003-02-17 2006-03-15 艾塔那法玛公司 含有咪唑并吡啶的组合和其在治疗胃肠炎性病症中的用途
EP1613637A1 (en) * 2003-04-03 2006-01-11 ALTANA Pharma AG Process for the production of imidazopyridin-8-ones
AR044129A1 (es) 2003-05-06 2005-08-24 Altana Pharma Ag Compuestos intermedios de imidazopiridina. proceso de preparacion.
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
AR046941A1 (es) * 2003-12-19 2006-01-04 Altana Pharma Ag Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico
CA2549860A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
CA2582256A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
AR051375A1 (es) * 2004-10-15 2007-01-10 Altana Pharma Ag Imidazopiridinas difluoro substituidas
WO2008058990A1 (en) * 2006-11-16 2008-05-22 Nycomed Gmbh 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
WO1992021341A1 (en) * 1991-05-31 1992-12-10 Pfizer Inc. Use of rapamycin prodrugs as immunosuppressant agents
DE4308095A1 (de) * 1993-03-13 1994-09-15 Hoechst Ag Prodrug-Derivate von Arzneimittelwirkstoffen mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
SE9401197D0 (sv) 1994-04-11 1994-04-11 Astra Ab Active compounds
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
ZA982445B (en) * 1997-03-24 1998-09-24 Byk Gulden Lomberg Chem Fab Tetrahydropyrido compounds
DK0971922T3 (da) * 1997-03-24 2004-08-16 Altana Pharma Ag Tetrahydropyrido-forbindelser
CN101255164A (zh) 1997-05-28 2008-09-03 奥坦纳医药公司 稠合的二氢吡喃类化合物及其用途
HUP0102990A3 (en) * 1998-09-23 2002-09-30 Altana Pharma Ag Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
AU1044500A (en) * 1998-11-03 2000-05-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazonaphthyridines
DE60002855T2 (de) * 1999-04-17 2004-05-06 Altana Pharma Ag Haloalkoxy-imidazonaphthyridine
US20030125327A1 (en) * 2000-03-29 2003-07-03 Senn-Bilfinger J?Ouml;Rg Prodrugs of imidazopyridine derivatives
SK13872002A3 (sk) * 2000-03-29 2003-02-04 Altana Pharma Ag Alkylové imidazopyridínové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
JP2003528877A (ja) * 2000-03-29 2003-09-30 アルタナ ファルマ アクチエンゲゼルシャフト 胃腸疾患の処置のためのピラノ[2,3−c]イミダゾ[−1,2−a]ピリジン誘導体
AU783724B2 (en) 2000-03-29 2005-12-01 Altana Pharma Ag Tricyclic imidazopyridines
CN1692113A (zh) * 2000-10-25 2005-11-02 奥坦纳医药公司 作为胃分泌抑制剂的多取代咪唑并吡啶

Also Published As

Publication number Publication date
MXPA03003706A (es) 2005-01-25
BR0114873A (pt) 2003-07-01
CN1692113A (zh) 2005-11-02
US7141567B2 (en) 2006-11-28
EA008151B1 (ru) 2007-04-27
JP2004512338A (ja) 2004-04-22
HRP20030323A2 (hr) 2005-04-30
WO2002034749A1 (en) 2002-05-02
NO20031830D0 (no) 2003-04-24
US6869949B2 (en) 2005-03-22
EA200300478A1 (ru) 2003-12-25
KR20040011423A (ko) 2004-02-05
ZA200302038B (en) 2004-04-22
AU2002210563B2 (en) 2007-03-01
IL154850A0 (en) 2003-10-31
AU1056302A (en) 2002-05-06
PL360412A1 (en) 2004-09-06
SK5072003A3 (en) 2003-09-11
CA2426616A1 (en) 2002-05-02
NO325736B1 (no) 2008-07-14
HUP0302308A2 (hu) 2003-11-28
EP1332143A1 (en) 2003-08-06
US20040106642A1 (en) 2004-06-03
US20040214852A1 (en) 2004-10-28
NZ525281A (en) 2004-11-26

Similar Documents

Publication Publication Date Title
NO20005450D0 (no) Imidazopyridinderivater som inhiberer magesyresekresjon
NO20030055D0 (no) Colchinolderivater som angiogenese inhibitorer
NO20023828L (no) Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
NO20021239D0 (no) Pteridinoner som kinase-inhibitorer
NO20012337L (no) Fremgangsmåte for sementering av underjordiske soner
NO20030867L (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
CY2014018I2 (el) Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
NO20041887L (no) Benzomidazoler anvendelige som proteinkinase-inhibitorer
EE200300273A (et) Asendatud imidasopüridiinid
NO20031450L (no) Fumarsyrederivater som NF-kappa B inhibitorer
DK1140840T3 (da) omega-carboxyaryl-substituerede diphenylurinstoffer som raf-kinase-inhibitorer
DK1289985T3 (da) Beta-carbolinderivater anvendelige som phosphodiesteraseinhibitorer
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
NO20022139L (no) Kinazolinderivater som VEGF inhibitorer
NO20031830D0 (no) Polysubstituerte imidazopyridiner som gastriske sekresjonshemmere
NO20015065D0 (no) Pyrazolobenzodiazepiner som CDK2-inhibitorer
NO20014483L (no) Aminderivater som proteaseinhibitorer
NO20014675D0 (no) Fremgangsmåter for sementering i underjordiske soner
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
PT1339695E (pt) Inibidores da farnesiltransferase
FI20020884A0 (fi) Porausmenetelmä
FI20010896A0 (fi) Linjatestausjärjestely
DK1690853T3 (da) Omega-carboxyaryl-substituerede diphenylurinstoffer til anvendelse som raf-kinaseinhibitorer
DE50104434D1 (de) Lactam-substituierte pyrazolopyridinderivate
NO20035806L (no) Fremgangsmåte for flash-karbonisering av biomasse

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104